NAGE Q2 2018 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+85.0% YoY

Gross Profit

$4M49.3% margin

Operating Income

-$8M-101.7% margin

Net Income

-$8M-103.2% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+18.8%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$52M

Total Liabilities

$12M

Stockholders' Equity

$41M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$4M	+85.0%
Gross Profit	$4M	$2M	+82.4%
Operating Income	-$8M	-$3M	-199.5%
Net Income	-$8M	-$3M	-191.2%